Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 30 (RPL17P30)

Target
RPL17P30
Molecular classification
Other, Pseudogene, Ribosomal protein pseudogene
01

Overview

Ribosomal protein L17 pseudogene 30 (RPL17P30) is a processed pseudogene in the human genome that shares sequence similarity with the functional ribosomal protein L17 gene (RPL17). Like most ribosomal protein pseudogenes, RPL17P30 does not encode a functional protein and does not play a direct role in cellular processes or disease. The human genome contains a large number of ribosomal protein pseudogenes, which are considered non-functional genetic elements derived from duplication or retrotransposition events[6]. While the parent gene (RPL17) encodes a component of the large ribosomal subunit, the pseudogene copy is not involved in protein synthesis or other ribosomal functions[6][2][4].\n\nPseudogene status: RPL17P30 is a non-coding processed pseudogene, meaning it lacks promoter or coding potential due to frame disruptions or truncations and typically accumulates mutations over evolutionary time[6][2].\nNot a therapeutic target: Pseudogenes are not utilized as drug targets, biomarkers, or candidates for mechanism of action studies in current biomedical practice[6].\nIf you require information about the functional parent gene (RPL17), that gene encodes a structural ribosomal protein involved in protein synthesis, but this is distinct from the pseudogene described above[4].

Other names
RPL17_20_898RPL17P30
02

Biological functions

Other (no direct biological function; does not encode a functional protein)
03

Disease associations

Other (no known direct roles in disease, as it does not produce a protein)

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 30 (RPL17P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 30 (RPL17P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call